We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+7.87%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$9.04B
AUM Growth
+$2.19B
Cap. Flow
+$1.88B
Cap. Flow %
20.78%
Top 10 Hldgs %
34.88%
Holding
3,092
New
1,032
Increased
581
Reduced
587
Closed
820

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$435M
2
AMZN icon
Amazon
AMZN
+$334M
3
MRNA icon
Moderna
MRNA
+$53.9M
4
LIN icon
Linde
LIN
+$44.2M
5
DTE icon
DTE Energy
DTE
+$43.5M

Sector Composition

Rank Sector Weight
1 Technology 15.37%
2 Consumer Discretionary 10.36%
3 Financials 7.14%
4 Industrials 6.8%
5 Healthcare 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRG icon
1201
PROG Holdings
PRG
$1.59B
$684K 0.01%
14,210
-4,415
-24% -$220K
OCDX
1202
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
$684K 0.01%
+31,931
New +$649K
EFX icon
1203
Equifax
EFX
$22.5B
$681K 0.01%
+2,842
New +$635K
PATK icon
1204
Patrick Industries
PATK
$2.74B
$679K 0.01%
+13,955
New +$798K
AAN
1205
DELISTED
The Aaron's Company Inc
AAN
$678K 0.01%
+21,192
New +$668K
SDC
1206
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$678K 0.01%
78,114
+39,105
+100% +$361K
NRC icon
1207
NRC Health Common Stock
NRC
$487M
$677K 0.01%
+14,757
New +$702K
ORA icon
1208
Ormat Technologies
ORA
$6.53B
$675K 0.01%
9,702
-10,572
-52% -$752K
ORGN
1209
DELISTED
Origin Materials
ORGN
$673K 0.01%
2,737
-13,261
-83% -$3.95M
PUMP icon
1210
ProPetro Holding
PUMP
$1.3B
$672K 0.01%
73,363
+20,679
+39% +$214K
EGHT icon
1211
8x8 Inc
EGHT
$282M
$670K 0.01%
24,152
+46
+0.2% +$1.3K
ZIM icon
1212
ZIM Integrated Shipping Services
ZIM
$3.38B
$664K 0.01%
+14,783
New +$570K
RKT icon
1213
Rocket Companies
RKT
$40.5B
$663K 0.01%
34,251
+19,880
+138% +$402K
ARCH
1214
DELISTED
Arch Resources, Inc.
ARCH
$662K 0.01%
11,623
-16,519
-59% -$863K
ABCL icon
1215
AbCellera Biologics
ABCL
$4.05B
$659K 0.01%
29,972
+20,729
+224% +$572K
MMS icon
1216
Maximus
MMS
$3.06B
$657K 0.01%
+7,474
New +$685K
ATH
1217
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$657K 0.01%
9,732
-7,486
-43% -$450K
MNTK icon
1218
Montauk Renewables
MNTK
$259M
$655K 0.01%
85,546
-45,954
-35% -$441K
TMC icon
1219
TMC The Metals Company
TMC
$2.19B
$653K 0.01%
+65,612
New +$652K
MBT
1220
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$653K 0.01%
70,547
-275
-0.4% -$2.44K
FOR icon
1221
Forestar Group
FOR
$1.48B
$652K 0.01%
31,188
-7,040
-18% -$165K
CPB icon
1222
Campbell Soup
CPB
$7B
$650K 0.01%
14,257
+10,256
+256% +$494K
WST icon
1223
West Pharmaceutical
WST
$24.5B
$650K 0.01%
+1,810
New +$598K
RAVN
1224
DELISTED
Raven Industries Inc
RAVN
$650K 0.01%
+11,235
New +$489K
VECO icon
1225
Veeco
VECO
$2.91B
$649K 0.01%
27,011
-34,015
-56% -$779K

Similar funds

Michael Gelband's Q2 2021 Portfolio in Review

As of Q2 2021, Michael Gelband held 3,092 positions worth $9.04B, up 32% from $6.86B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Michael Gelband deployed $1.88B of net new capital in Q2 2021, opening 1,032 new positions and adding to 581 existing holdings. Its largest new stake was Linde: 151,692 shares worth $43.9M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $63.6M trimmed.

  • Michael Gelband's largest Q2 2021 buy was Linde: 151,692 shares worth $43.9M.
  • Michael Gelband added most to Microsoft in Q2 2021, an estimated $435M increase.
  • Michael Gelband's biggest Q2 2021 reduction was iShares Russell 1000 Value ETF, cutting an estimated $63.6M.
  • Michael Gelband fully exited Charles River Laboratories in Q2 2021, selling an estimated $27.9M.
  • Michael Gelband's ten largest holdings make up 35% of its $9.04B portfolio in Q2 2021.
  • Michael Gelband opened 1,032 new positions and closed 820 in Q2 2021.
  • Michael Gelband's portfolio value rose 32% quarter-over-quarter to $9.04B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.